The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xarelto was produced by Bayer and Johnson & Johnson.
Other directly-acting or ‘novel orally acting anticoagulants’ (NOACs) include Bayer/Johnson &Johnson's Xarelto (rivaroxaban) and Daiichi Sankyo's Lixiana/Savaysa – which like Eliquis are Factor Xa inhibitors – and Boehringer
The results, as depicted in the chart, suggest that patients are equally likely to promote Xarelto and Eliquis, despite the latter earning more confidence. ... Are Lixiana users missing the confidence that Xarelto and Eliquis users have, and is this what
He was part of the WPP team that won the global account for Xarelto, tasked with re- imagining Bayer’s biggest selling drug.
It was rejected by the CHMP a year ago. Ondexxya is intended for use in patients taking Pfizer/Bristol-Myers Squibb's Eliquis (apixaban), Bayer/Johnson &Johnson's Xarelto (rivaroxaban) as
Blockbuster Xarelto declines 14% due to US competition. Johnson &Johnson has released fourth quarter results showing better than expected overall growth, but also signs of a squeeze on some of its ... This includes cardiovascular blockbuster Xarelto,
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...